Medicare Enrolled

Dr. Ari Umutyan, M.D.

Hematology & Oncology · Saint Helena, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
10 WOODLAND RD, Saint Helena, CA 94574
7079675721
In practice since 2005 (20 years)
NPI: 1275516171 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Umutyan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Umutyan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Umutyan

Dr. Ari Umutyan is a hematology & oncology specialist in Saint Helena, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Umutyan performed 429 Medicare services across 317 unique beneficiaries.

Between the years covered by Open Payments, Dr. Umutyan received a total of $5,097 from 47 pharmaceutical and/or device companies across 175 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Umutyan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 429 Medicare services $5,097 industry payments

Medicare Practice Summary

Medicare Utilization ↗
429
Medicare services
Bottom 32% in CA for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
317
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~21 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
126 $67 $184
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
99 $90 $252
New patient office visit, complex (60-74 min) 39 $137 $182
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
34 $130 $330
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
34 $98 $229
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
26 $147 $442
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
25 $54 $159
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
17 $11 $40
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $106 $145
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
12 $82 $240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,097
Total received (2018-2024)
Avg $728/year across 7 years
Top 43% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
175
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,438 (87.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$659 (12.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,698
2023
$583
2022
$531
2021
$785
2020
$204
2019
$522
2018
$773

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$266
Merck Sharp & Dohme LLC
$247
Janssen Biotech, Inc.
$183
AstraZeneca Pharmaceuticals LP
$160
Novartis Pharmaceuticals Corporation
$151
Genentech USA, Inc.
$136
ABBVIE INC.
$134
Daiichi Sankyo Inc.
$82
Myriad Genetic Laboratories, Inc.
$77
Celgene Corporation
$50
Sumitomo Pharma America, Inc.
$46
Regeneron Healthcare Solutions, Inc.
$39
Bayer Healthcare Pharmaceuticals Inc.
$35
ARRAY BIOPHARMA INC
$31
E.R. Squibb & Sons, L.L.C.
$21
Gilead Sciences, Inc.
$21
Eisai Inc.
$20
Top 3 companies account for 40.9% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$757
Genentech USA, Inc.
$439
Daiichi Sankyo Inc.
$354
AstraZeneca Pharmaceuticals LP
$331
Merck Sharp & Dohme LLC
$306
Janssen Biotech, Inc.
$283
Novartis Pharmaceuticals Corporation
$262
Myriad Genetic Laboratories, Inc.
$252
GE HealthCare
$181
ABBVIE INC.
$156
Puma Biotechnology, Inc.
$153
Celgene Corporation
$139
Regeneron Healthcare Solutions, Inc.
$129
AMAG Pharmaceuticals, Inc.
$116
Merck Sharp & Dohme Corporation
$92
Amgen Inc.
$83
Takeda Pharmaceuticals U.S.A., Inc.
$76
Medtronic, Inc.
$73
Gilead Sciences, Inc.
$61
Seagen Inc.
$52
Acrotech Biopharma LLC
$52
Pharmacyclics LLC, An AbbVie Company
$50
Exelixis Inc.
$50
Sumitomo Pharma America, Inc.
$46
Foundation Medicine, Inc.
$45
Eisai Inc.
$39
Seattle Genetics, Inc.
$36
Astellas Pharma US Inc
$36
Bayer Healthcare Pharmaceuticals Inc.
$35
Dendreon Pharmaceuticals LLC
$34
TAIHO ONCOLOGY, INC.
$34
ARRAY BIOPHARMA INC
$31
TESARO, Inc.
$28
Kyowa Kirin, Inc.
$27
Novocure Inc.
$26
Bayer HealthCare Pharmaceuticals Inc.
$25
AbbVie, Inc.
$24
Lilly USA, LLC
$24
Taiho Oncology, Inc.
$23
E.R. Squibb & Sons, L.L.C.
$21
Sirtex Medical Inc
$20
Janssen Pharmaceuticals, Inc
$17
Lexicon Pharmaceuticals, Inc.
$17
Siemens Medical Solutions USA, Inc.
$17
Teleflex LLC
$16
Bard Peripheral Vascular, Inc.
$15
Incyte Corporation
$13
Top 3 companies account for 30.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ARIA Radiation Therapy Management Software · Abraxane · Alecensa · Aranesp · BAVENCIO · BELEODAQ · BOSULIF · BRAFTOVI · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · ELAHERE · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Enhertu · FERAHEME · FOUNDATIONONE · Fabhalta · IBRANCE · IMBRUVICA · INLYTA · INTRAROSA · Imbruvica · Itovebi · JADENU · JAKAFI · KEYTRUDA · Kadcyla · LIBTAYO · LONSURF · LUMAKRAS · LUPRON DEPOT · LYNPARZA · Lenvima · Lonsurf · MANTA Vascular Closure Device · MEKINIST · MYRISK · NINLARO · Nerlynx · Neulasta · Nubeqa · OPDUALAG · ORGOVYX · Optune · PADCEV · PLUVICTO · PRALUENT ALIROCUMAB INJECTION · PRECISETUMOR · PROVENGE · Phesgo · Polivy · Pomalyst · Poteligeo · PreciseTumor · REBLOZYL · RYBREVANT · SCEMBLIX · SIGNIA · SIR-Spheres Microspheres · SUTENT · TAGRISSO · TECENTRIQ · VOTRIENT · Venclexta · XARELTO · XTANDI · Xermelo · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Saint Helena?
Compare hematology & oncology specialists in the Saint Helena area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
13
Per 100K population
9.6
County median income
$108,970
Nearest hospital
ADVENTIST HEALTH ST HELENA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Umutyan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Umutyan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Umutyan performed 126 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Umutyan receive payments from pharmaceutical companies?
Yes. Dr. Umutyan received a total of $5,097 from 47 companies across 175 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Umutyan's costs compare to other hematology & oncology specialists in Saint Helena?
Dr. Umutyan's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Umutyan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →